| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 268 | 2021 |
| Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 … F Raffi, AG Babiker, L Richert, JM Molina, EC George, A Antinori, ... The Lancet 384 (9958), 1942-1951, 2014 | 228 | 2014 |
| Opportunistic infections occurring during highly active antiretroviral treatment C Michelet, C Arvieux, C François, JM Besnier, JP Rogez, JP Breux, ... Aids 12 (14), 1815-1822, 1998 | 221 | 1998 |
| Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor S Grabar, C Pradier, E Le Corfec, R Lancar, C Allavena, M Bentata, ... Aids 14 (2), 141-149, 2000 | 196 | 2000 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 142 | 2022 |
| Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated … C Orrell, DP Hagins, E Belonosova, N Porteiro, S Walmsley, V Falcó, ... The Lancet HIV 4 (12), e536-e546, 2017 | 138 | 2017 |
| A large French prospective cohort of HIV‐infected patients: the Nadis Cohort P Pugliese, L Cuzin, A Cabié, I Poizot‐Martin, C Allavena, C Duvivier, ... HIV medicine 10 (8), 504-511, 2009 | 129 | 2009 |
| High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs C Allavena, C Delpierre, L Cuzin, D Rey, N Viget, J Bernard, P Guillot, ... Journal of Antimicrobial Chemotherapy 67 (9), 2222-2230, 2012 | 128 | 2012 |
| Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission A Cheret, C Bacchus-Souffan, V Avettand-Fenoël, A Mélard, G Nembot, ... Journal of Antimicrobial Chemotherapy 70 (7), 2108-2120, 2015 | 119 | 2015 |
| Prevalence and risk factors of sleep disturbance in a large HIV-infected adult population C Allavena, T Guimard, E Billaud, S De la Tullaye, V Reliquet, S Pineau, ... AIDS and Behavior 20, 339-344, 2016 | 107 | 2016 |
| Causes of the first AIDS‐defining illness and subsequent survival before and after the advent of combined antiretroviral therapy* S Grabar, E Lanoy, C Allavena, M Mary‐Krause, M Bentata, P Fischer, ... HIV medicine 9 (4), 246-256, 2008 | 103 | 2008 |
| Relationship of trace element, immunological markers, and HIV1 infection progression C Allavena, B Dousset, T May, F Dubois, P Canton, F Belleville Biological trace element research 47, 133-138, 1995 | 85 | 1995 |
| A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection C Bacchus, A Cheret, V Avettand-Fenoël, G Nembot, A Mélard, C Blanc, ... PLoS one 8 (5), e64219, 2013 | 79 | 2013 |
| Antiretroviral exposure and comorbidities in an aging HIV-infected population: the challenge of geriatric patients C Allavena, M Hanf, D Rey, C Duvivier, F BaniSadr, I Poizot-Martin, ... PloS one 13 (9), e0203895, 2018 | 75 | 2018 |
| High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients D Rey, B Hoen, P Chavanet, MP Schmitt, G Hoizey, P Meyer, G Peytavin, ... Journal of antimicrobial chemotherapy 63 (2), 380-388, 2009 | 72 | 2009 |
| Dolutegravir monotherapy versus dolutegravir/abacavir/lamivudine for virologically suppressed people living with chronic human immunodeficiency virus infection: the randomized … L Hocqueloux, F Raffi, T Prazuck, L Bernard, S Sunder, JL Esnault, D Rey, ... Clinical Infectious Diseases 69 (9), 1498-1505, 2019 | 71 | 2019 |
| Prevalence of and factors associated with depression among people living with HIV in France P Feuillet, F Lert, L Tron, C Aubriere, B Spire, R Dray‐Spira, ... HIV medicine 18 (6), 383-394, 2017 | 67 | 2017 |
| Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort D Lebrun, M Hentzien, L Cuzin, D Rey, V Joly, L Cotte, C Allavena, ... Aids 31 (15), 2159-2166, 2017 | 62 | 2017 |
| Prolonged hepatitis A infection in an HIV‐1 seropositive patient M Costa‐Mattioli, C Allavena, AS Poirier, S Billaudel, F Raffi, V Ferré Journal of medical virology 68 (1), 7-11, 2002 | 62 | 2002 |
| Factors associated with mortality in human immunodeficiency virus type 1–infected adults initiating protease inhibitor–containing therapy: role of education level and of early … C Lewden, F Raffi, L Cuzin, V Cailleton, JL Vildé, G Chêne, C Allavena, ... The Journal of infectious diseases 186 (5), 710-714, 2002 | 62 | 2002 |
Lise CuzinTropical and Infectious Diseases, Fort de France, Martinique在 chu-martinique.fr 的电子邮件经过验证
